πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7632484

Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific dise

The Board of Regents of the University of Texas System Β· Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7627938

Tapered hollow metallic microneedle array assembly and method of making and using the same

The Board of Regents of the University of Texas System Β· Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7629308

Methods relating to muscle selective calcineurin interacting protein (MCIP)

The Board of Regents of the University of Texas System Β· Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7625563

Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7622118

Cancer treatment methods using selected antibodies to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7619000

S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino)

The Board of Regents of the University of Texas System Β· Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7618630

Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin an

The Board of Regents of the University of Texas System Β· Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7615223

Selected immunoconjugates for binding to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7615208

Metal ion-labeled bis-aminoethanethiol-targeting ligand conjugates, compositions, and meth

The Board of Regents of the University of Texas System Β· Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7611704

Compositions and methods for treating viral infections using antibodies and immunoconjugat

The Board of Regents of the University of Texas System Β· Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7611693

Mechanism-based targeted pancreatic beta cell imaging and therapy

The Board of Regents of the University of Texas System Β· Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7601731

Antimicrobial flush solutions

The Board of Regents of the University of Texas System Β· Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7601683

Protein conformational isomers, methods of making, methods for using, compositions compris

The Board of Regents of the University of Texas System Β· Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7601490

Development of influenza A antivirals

The Board of Regents of the University of Texas System Β· Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7582281

Ethylenedicysteine (EC)-drug conjugates compositions and methods for tissue specific disea

The Board of Regents of the University of Texas System Β· Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7579014

Mesoporous compositions for use in drug delivery

The Board of Regents of the University of Texas System Β· Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7576194

UspA2 nucleic acid of moraxella catarrhalis

The Board of Regents of the University of Texas System Β· Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7572448

Combined cancer treatment methods using selected antibodies to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7572442

Selected antibody compositions for binding to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7569683

UspA2 nucleic acid of Moraxella catarrhalis

The Board of Regents of the University of Texas System Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7563446

Methods and compositions for inducing autoimmunity in the treatment of cancers

The Board of Regents of the University of Texas System Β· Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7556942

Tumor suppressor designated Hippo

The Board of Regents of the University of Texas System Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7550617

Compositions and methods for the treatment of renal and cardiovascular disease

The Board of Regents of the University of Texas System Β· Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7550141

Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted